MedPath
HSA Approval

HYOSCINE BUTYLBROMIDE TABLET 10 mg

SIN03553P

HYOSCINE BUTYLBROMIDE TABLET 10 mg

HYOSCINE BUTYLBROMIDE TABLET 10 mg

July 4, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A03BB01

butylscopolamine

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

HYOSCINE BUTYLBROMIDE

10 mg

Hyoscine butylbromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYOSCINE BUTYLBROMIDE TABLET 10 mg - HSA Approval | MedPath